1-Cyclopentyl-7-((3,5-difluorophenyl)amino)-4,4-dimethyl-1,4-dihydro-2H-pyrimido[4,5-d][1,3]oxazin-2-one

ID: ALA4871187

PubChem CID: 164618626

Max Phase: Preclinical

Molecular Formula: C20H22F2N4O2

Molecular Weight: 388.42

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)cc(F)c3)ncc21

Standard InChI:  InChI=1S/C20H22F2N4O2/c1-11(2)17-16-10-23-19(24-14-8-12(21)7-13(22)9-14)25-18(16)26(20(27)28-17)15-5-3-4-6-15/h7-11,15,17H,3-6H2,1-2H3,(H,23,24,25)

Standard InChI Key:  YVPPZIPRIVLHJS-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   22.7039   -2.1998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5852   -2.6249    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.5841   -3.4444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2921   -3.8534    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.2903   -2.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9989   -2.6213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0023   -3.4465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7147   -3.8539    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.4283   -3.4406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4249   -2.6154    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.8760   -3.8525    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8754   -4.6696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1693   -5.0797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1683   -5.8961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8762   -6.3061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5866   -5.8937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5841   -5.0786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1371   -3.8473    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.7169   -4.6711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6974   -1.3826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4018   -0.9684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9864   -0.9797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0598   -5.1556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3144   -5.9321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1317   -5.9298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3819   -5.1519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2954   -6.3003    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   18.4601   -6.3038    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  7  2  0
  6  5  2  0
  5  2  1  0
  6  7  1  0
  6  1  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  1  1  0
  3 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  9 18  2  0
  8 19  1  0
  1 20  1  0
 20 21  1  0
 20 22  1  0
 19 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 19  1  0
 16 27  1  0
 14 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4871187

    ---

Associated Targets(Human)

RPS6KA6 Tchem Ribosomal protein S6 kinase alpha 6 (2027 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 388.42Molecular Weight (Monoisotopic): 388.1711AlogP: 5.09#Rotatable Bonds: 4
Polar Surface Area: 67.35Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.59CX Basic pKa: 1.41CX LogP: 5.18CX LogD: 5.18
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.79Np Likeness Score: -0.79

References

1. Yuan Y, Xu J, Jiang L, Yu K, Ge Y, Li M, He H, Niu Q, Shi X, Fan L, Chen Z, Zhao Z, Li S, Xu Y, Wang Z, Li H..  (2021)  Discovery, Optimization, and Structure-Activity Relationship Study of Novel and Potent RSK4 Inhibitors as Promising Agents for the Treatment of Esophageal Squamous Cell Carcinoma.,  64  (18.0): [PMID:34496560] [10.1021/acs.jmedchem.1c00969]

Source